Updated Results from a Phase I/II Study of the Triplet Combination of Azacitidine, Venetoclax and Gilteritinib for Patients with <i>FLT3</i>-Mutated Acute Myeloid Leukemia

Nicholas J. Short, Courtney D. DiNardo, Naval Daver, Walid Macaron, Musa Yılmaz, Gautam Borthakur, Guillermo Montalban‐Bravo, Guillermo Garcia‐Manero, Ghayas C. Issa, Koji Sasaki,

Blood · 2022 · 38 citations · 0 references

Concepts